Lazard Asset Management Portfolio holdings
AUM
$72.7B
This Quarter Return
+0.1%
1 Year Return
+14.89%
3 Year Return
+61.14%
5 Year Return
+112.7%
10 Year Return
+262.42%
AUM
$68.4B
AUM Growth
+$68.4B
(-8.6%)
Cap. Flow
-$5.31B
Cap. Flow
% of AUM
-7.76%
Top 10 Holdings %
Top 10 Hldgs %
25.74%
Holding
2,627
New
281
Increased
832
Reduced
890
Closed
234
Top Buys
| 1 |
Eli Lilly
LLY
|
$404M |
| 2 |
Merck
MRK
|
$276M |
| 3 |
Jacobs Solutions
J
|
$255M |
| 4 |
Equifax
EFX
|
$241M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$209M |
Top Sells
| 1 |
Microsoft
MSFT
|
$702M |
| 2 |
Johnson & Johnson
JNJ
|
$536M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$520M |
| 4 |
Marvell Technology
MRVL
|
$448M |
| 5 |
Amazon
AMZN
|
$344M |
Sector Composition
| 1 | Technology | 26.04% |
| 2 | Financials | 14.62% |
| 3 | Healthcare | 12% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Interactive Brokers
IBKR
$27.7B
| $0 | ﹤0.01% | 3 | – | – |
|
2427
ImmunityBio
IBRX
$2.21B
| $0 | ﹤0.01% | 98 | – | – |
|